Premium
Real‐world data on treatment patterns and outcomes of hypomethylating therapy in patients with newly diagnosed acute myeloid leukaemia aged ≥ 60 years
Author(s) -
Österroos Albin,
Eriksson Anna,
Antunovic Petar,
Cammenga Jörg,
Deneberg Stefan,
Lazarevic Vladimir,
Lorenz Fryderyk,
Möllgård Lars,
Derolf Åsa R.,
Uggla Bertil,
Wennström Lovisa,
Ölander Emma,
Höglund Martin,
Juliusson Gunnar,
Lehmann Sören
Publication year - 2020
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/bjh.16410
Subject(s) - medicine , decitabine , cytarabine , myeloid leukaemia , acute promyelocytic leukemia , myeloid leukemia , population , azacitidine , pediatrics , oncology , biochemistry , gene expression , dna methylation , gene , chemistry , retinoic acid , environmental health